MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also of… Read more
MeVis Medical Solutions AG (M3V) - Net Assets
Latest net assets as of September 2025: €17.83 Million EUR
Based on the latest financial reports, MeVis Medical Solutions AG (M3V) has net assets worth €17.83 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€25.89 Million) and total liabilities (€8.06 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €17.83 Million |
| % of Total Assets | 68.86% |
| Annual Growth Rate | 10.55% |
| 5-Year Change | N/A |
| 10-Year Change | -45.8% |
| Growth Volatility | 237.43 |
MeVis Medical Solutions AG - Net Assets Trend (2006–2025)
This chart illustrates how MeVis Medical Solutions AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MeVis Medical Solutions AG (2006–2025)
The table below shows the annual net assets of MeVis Medical Solutions AG from 2006 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | €17.83 Million | 0.00% |
| 2024-09-30 | €17.83 Million | 0.00% |
| 2023-09-30 | €17.83 Million | 0.00% |
| 2022-09-30 | €17.83 Million | +0.00% |
| 2021-09-30 | €17.83 Million | 0.00% |
| 2020-09-30 | €17.83 Million | 0.00% |
| 2019-09-30 | €17.83 Million | -44.40% |
| 2018-09-30 | €32.06 Million | -1.39% |
| 2017-09-30 | €32.51 Million | -1.15% |
| 2016-09-30 | €32.89 Million | -2.49% |
| 2015-09-30 | €33.73 Million | +11.43% |
| 2014-09-30 | €30.27 Million | +14.46% |
| 2013-09-30 | €26.45 Million | +16.14% |
| 2012-09-30 | €22.77 Million | +9.84% |
| 2011-09-30 | €20.73 Million | -16.38% |
| 2010-09-30 | €24.79 Million | -23.98% |
| 2009-09-30 | €32.61 Million | -0.01% |
| 2008-09-30 | €32.61 Million | +5.99% |
| 2007-09-30 | €30.77 Million | +1059.78% |
| 2006-09-30 | €2.65 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to MeVis Medical Solutions AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 74.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €4.54 Million | 25.47% |
| Common Stock | €1.82 Million | 10.21% |
| Other Components | €11.47 Million | 64.32% |
| Total Equity | €17.83 Million | 100.00% |
MeVis Medical Solutions AG Competitors by Market Cap
The table below lists competitors of MeVis Medical Solutions AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Centrale d'Achat Francaise pour l' Outre Mer
LSE:0HRB
|
$12.89 Million |
|
Moksh Ornaments Limited
NSE:MOKSH
|
$12.89 Million |
|
Firetrade Engineering PCL
BK:FTE
|
$12.90 Million |
|
Aurora Spine Corporation
OTCQB:ASAPF
|
$12.90 Million |
|
Passus S.A.
WAR:PAS
|
$12.89 Million |
|
Dacome International Ltd
TWO:9960
|
$12.89 Million |
|
Morixe Hermanos SACI
BA:MORI
|
$12.89 Million |
|
DELTA RES LTD
F:6GO1
|
$12.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MeVis Medical Solutions AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 17,826,020 to 17,826,020, a change of 0 (0.0%).
- Net income of 3,165,924 contributed positively to equity growth.
- Dividend payments of 4,560,821 reduced retained earnings.
- Other comprehensive income decreased equity by 5,000.
- Other factors increased equity by 1,399,897.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €3.17 Million | +17.76% |
| Dividends Paid | €4.56 Million | -25.59% |
| Other Comprehensive Income | €-5.00K | -0.03% |
| Other Changes | €1.40 Million | +7.85% |
| Total Change | €- | 0.00% |
Book Value vs Market Value Analysis
This analysis compares MeVis Medical Solutions AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.67x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.33x to 2.67x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-09-30 | €4.91 | €26.20 | x |
| 2007-09-30 | €39.98 | €26.20 | x |
| 2008-09-30 | €18.73 | €26.20 | x |
| 2009-09-30 | €19.18 | €26.20 | x |
| 2010-09-30 | €14.51 | €26.20 | x |
| 2011-09-30 | €12.05 | €26.20 | x |
| 2012-09-30 | €13.22 | €26.20 | x |
| 2013-09-30 | €15.35 | €26.20 | x |
| 2014-09-30 | €17.57 | €26.20 | x |
| 2015-09-30 | €18.65 | €26.20 | x |
| 2016-09-30 | €17.88 | €26.20 | x |
| 2017-09-30 | €17.86 | €26.20 | x |
| 2018-09-30 | €17.61 | €26.20 | x |
| 2019-09-30 | €9.79 | €26.20 | x |
| 2020-09-30 | €9.79 | €26.20 | x |
| 2021-09-30 | €9.79 | €26.20 | x |
| 2022-09-30 | €9.79 | €26.20 | x |
| 2023-09-30 | €9.79 | €26.20 | x |
| 2024-09-30 | €9.79 | €26.20 | x |
| 2025-09-30 | €9.79 | €26.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MeVis Medical Solutions AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.76%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 19.71%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 1.45x
- Recent ROE (17.76%) is below the historical average (19.60%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 110.63% | 35.18% | 0.92x | 3.43x | €2.67 Million |
| 2007 | 0.43% | 1.67% | 0.22x | 1.16x | €-2.94 Million |
| 2008 | 6.48% | 19.49% | 0.18x | 1.83x | €-1.15 Million |
| 2009 | 1.22% | 2.87% | 0.27x | 1.56x | €-2.86 Million |
| 2010 | -33.68% | -58.42% | 0.37x | 1.56x | €-10.83 Million |
| 2011 | -19.74% | -29.92% | 0.42x | 1.57x | €-6.16 Million |
| 2012 | 9.50% | 16.21% | 0.43x | 1.36x | €-112.90K |
| 2013 | 13.92% | 25.18% | 0.43x | 1.30x | €1.04 Million |
| 2014 | 12.27% | 28.36% | 0.34x | 1.26x | €686.00K |
| 2015 | 19.97% | 42.06% | 0.35x | 1.35x | €3.36 Million |
| 2016 | 13.89% | 28.33% | 0.37x | 1.31x | €1.28 Million |
| 2017 | 17.29% | 30.32% | 0.38x | 1.51x | €2.37 Million |
| 2018 | 22.37% | 42.79% | 0.44x | 1.20x | €3.97 Million |
| 2019 | 45.28% | 44.66% | 0.76x | 1.34x | €6.29 Million |
| 2020 | 32.00% | 33.30% | 0.62x | 1.56x | €3.92 Million |
| 2021 | 25.50% | 28.04% | 0.59x | 1.54x | €2.76 Million |
| 2022 | 43.69% | 41.52% | 0.60x | 1.75x | €6.01 Million |
| 2023 | 27.60% | 28.37% | 0.62x | 1.57x | €3.14 Million |
| 2024 | 25.59% | 26.87% | 0.64x | 1.49x | €2.78 Million |
| 2025 | 17.76% | 19.71% | 0.62x | 1.45x | €1.38 Million |
Industry Comparison
This section compares MeVis Medical Solutions AG's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $2,006,158,071
- Average return on equity (ROE) among peers: -15.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MeVis Medical Solutions AG (M3V) | €17.83 Million | 110.63% | 0.45x | $12.89 Million |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |